8-KMaterial AgreementsOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Material Agreement (Jun 6, 2007)

Filed June 6, 2007For Securities:COR

Summary

Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on June 5, 2007, reporting on key developments related to the planned spin-off and combination of its institutional pharmacy business with Kindred Healthcare's institutional pharmacy operations to form a new entity, PharMerica Corporation. The most significant update for investors is the amendment to the Master Transaction Agreement, which extends the termination date to September 30, 2007. This extension suggests a potential delay in the original timeline and provides additional flexibility for the parties involved in finalizing the complex transaction. Furthermore, the company announced the appointment of four key executives who will lead PharMerica Corporation and reiterated an updated target closing date of July 31, 2007. This move signals progress in establishing the leadership structure for the new company, though the extension of the termination date may cause some uncertainty regarding the final closing. Investors should monitor the progress towards the July 31st target and be aware of the implications of the September 30th termination date.

Key Highlights

  • 1Amendment to Master Transaction Agreement extends the termination date to September 30, 2007.
  • 2New target closing date for the formation of PharMerica Corporation is set for July 31, 2007.
  • 3Four executives have been appointed to lead the new entity, PharMerica Corporation.
  • 4The original expected closing timeframe during the second calendar quarter of 2007 has been revised.
  • 5The filing confirms the parties involved in the Master Transaction Agreement, including Cencora (Registrant), PharMerica, Inc., Kindred Healthcare, Inc., and various subsidiaries.

Frequently Asked Questions

This 8-K filing serves to update investors on the status of the planned spin-off and combination of Cencora's (then AmerisourceBergen's) institutional pharmacy business with Kindred Healthcare's operations to form a new company, PharMerica Corporation. It details an amendment to the transaction agreement and announces new leadership appointments.

The filing does not explicitly state the reason for the extension, but it indicates that the parties involved agreed to amend the Master Transaction Agreement to push the termination date to September 30, 2007. This suggests that additional time is needed to finalize the details and closing conditions of the complex transaction.

The press release included in the filing announces that the closing of the transaction to form PharMerica Corporation is now targeted to occur on July 31, 2007. This is a revision from the previous expectation of closing within the second calendar quarter of 2007.

The key parties involved in the Master Transaction Agreement and the formation of PharMerica Corporation include Cencora, Inc. (Registrant, formerly AmerisourceBergen Corporation), PharMerica, Inc., Kindred Healthcare, Inc., and their respective subsidiaries involved in the institutional pharmacy businesses.